What is Elvie?
Based in London, Elvie has established itself as a category leader by developing sophisticated pelvic floor trainer devices. The company utilizes a patented system of force and motion sensors to provide precise measurements of pelvic floor contractions, effectively bridging the gap between clinical-grade diagnostics and consumer-accessible wellness solutions. By integrating hardware innovation with digital health tracking, Elvie has successfully captured a significant share of the FemTech market, positioning itself as a vital player in the broader digital health ecosystem.
The company's growth trajectory has been marked by consistent investment rounds, starting from its early Series A phase to its current status as a mature enterprise-level entity. This evolution reflects a strategic focus on product refinement and international market expansion, ensuring that Elvie remains at the forefront of women's health technology.
How much funding has Elvie raised?
Elvie has raised a total of $157M across 4 funding rounds:
Series A
$6M
Series B
$42M
Series C
$97M
Other Financing Round
$12M
Series A (2017): $6M with participation from Octopus Ventures and AllBright
Series B (2019): $42M, investors not publicly disclosed
Series C (2021): $97M supported by Westerly Winds, IPGL, and Hiro Capital
Other Financing Round (2024): $12M, investors not publicly disclosed
Key Investors in Elvie
Westerly Winds
A firm dedicated to backing dynamic, visionary founders and companies that possess the potential to become integral components of the new economy.
IPGL
A private holding company that partners with experienced management teams to build fast-growing businesses and develop industry leaders over the long term.
Hiro Capital
A founder-led venture capital firm based in Europe, specializing in high-growth technology sectors including AI, robotics, and next-generation computing.
What's next for Elvie?
With the recent capital injection, Elvie is well-positioned to accelerate its strategic initiatives, including the expansion of its product portfolio and the enhancement of its digital health platform. The company's focus remains on scaling its operations to meet the rising global demand for personalized health monitoring tools. As Elvie continues to navigate the competitive FemTech landscape, the emphasis will likely shift toward deepening its technological moat and exploring new applications for its proprietary sensor technology. This strategic roadmap underscores the company's commitment to driving innovation in women's health, ensuring that it remains a dominant force in the industry for years to come.
See full Elvie company page
